MedPath

Effect of aerobic exercise and astaxanthin supplementation on humanin protein expressio

Not Applicable
Recruiting
Conditions
diabetes.
Type 2 diabetes mellitus
Registration Number
IRCT20230225057524N1
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
75
Inclusion Criteria

Minimum age 30 and maximum 55 years
Excessive hyperglycemia (HbA1c > 10%)
Diabetic microvascular complications
Diabetic neuropathy
Impaired liver function (plasma aminotransferase and/or g-glutamyltransferase level above the upper limit of normal for age and sex)
Renal dysfunction (serum creatinine level higher than normal for age and sex)
Severe anemia
Uncontrolled blood pressure (blood pressure > 100/170 mm Hg)
Obvious heart-related symptoms or history of cerebrovascular events
Patients with cardiovascular disease (class I-IV congestive heart failure or history of myocardial infarction)
Patients on insulin therapy will not be eligible
Active patients who reported more than 1 exercise per week

Exclusion Criteria

Patients treated with insulin
Having no history of cardiovascular diseases and respiratory problems
Patients who do sports.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of women with type 2 diabetes. Timepoint: Before the intervention, 8 weeks after the intervention. Method of measurement: Blood sugar test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath